Proyekta Data Solutions | Leading Financial Intelligence for Healthcare in Colombia. Over 250 healthcare organizations analyzed. Intelligence for smarter decisions.

top of page

WhatsApp Image 2026-08-17 at 12.45.54 AM.jpeg

We understand where the market is.

Where Financial Intelligence meets Healthcare Market Intelligence.

300+ healthcare organizations in Colombia analyzed. Intelligence for smarter decisions.

ejemplo portada.jpg

image (1).png

VALUE PROPOSITION

1. Combining Healthcare market intelligence with advanced financial analytics to deliver deeper insights for investors, healthcare providers, pharmaceutical companies, and medical device manufactures.

2. Financial Intelligence Beyond Traditional Analytic.

We combine quantitative finance, forensic analytics, and statistical modeling to uncover hidden risks, assess enterprise value, and empower confident, evidence-based decisions.

We uncover financial risks and business value that traditional analysis fails to detect.

QUANTITATIVE FINANCIAL ADVISORY
VALUATION, FORENSICS & CREDIT ANALYTICS

We determine what a company is truly worth — not what the market hopes, not what management projects, and not what a spreadsheet casually suggests.

Our valuation framework integrates:

Advanced discounted cash flow modeling
Risk-structured WACC calibration
Capital allocation efficiency analysis
Industry structural positioning
Scenario-based stress testing
Downside protection modeling

We challenge assumptions. We deconstruct projections. We pressure-test growth narratives.

This is not a template valuation.

This is capital-grade analysis.

Deliverable: A defensible, investment-level valuation built to withstand scrutiny from private equity, institutional investors, boards, and litigation environments.

We deconstruct financial structures to uncover distortions, hidden fragilities, and structural risk.

This is not accounting.
This is quantitative financial intelligence.

Our methodology integrates advanced statistical techniques applied to real financial data, including:

Multivariate financial diagnostic models
Vector-based structural indicator analysis
Statistical anomaly and outlier detection
Probability and transition modeling (Markov frameworks)
Exponential smoothing and predictive modeling
Cross-sectional industry consistency testing

We do not merely review financial statements.

We test the mathematical coherence of financial behavior over time.

Our analysis identifies what traditional reviews fail to detect:

- Earnings quality deterioration, liquidity illusion, capital misallocation, systemic risk accumulation, and early signals of structural stress.

- Every conclusion is evidence-based, model-driven, and statistically validated.

Deliverable: Defensible financial intelligence grounded in quantitative rigor and designed to support high-stakes strategic decisions.

We determine true borrowing capacity through a quantitative framework that integrates earnings quality diagnostics, insolvency probability modeling, and free cash flow sustainability assessment.

Our approach combines advanced credit scoring techniques with established financial distress and earnings manipulation detection models. Before defining any exposure level, we evaluate the structural coherence between reported earnings, cash generation, leverage, and default risk.

The analysis includes:

Earnings quality and abnormal accrual diagnostics
Probabilistic insolvency and financial distress modeling
Structural leverage and liquidity assessment
Free cash flow generation and consistency validation

We do not structure credit limits based on projected EBITDA or nominal growth assumptions.

Exposure is calibrated on validated financial strength, statistical deterioration risk, and effective cash-generating capacity.

Each credit limit is the result of quantitative modeling, cross-validation of financial metrics, and structural analysis of financial behavior over time.

Deliverable: Defensible credit limits aligned with true repayment capacity and probabilistic risk of financial deterioration.

Understanding the Economics of Clinics and Medical Practices.

This training is designed for physicians, medical directors, and healthcare professionals who make decisions within clinics, medical practices, and healthcare institutions but do not have formal financial training.

The program explains in a clear and practical way how the financial dynamics of healthcare organizations actually work. Participants will learn how to interpret financial statements, understand the cash flow of a clinic or medical practice, identify which medical services generate profitability, and recognize the financial factors that lead many healthcare institutions into financial distress.

The content is based on real financial analysis of the healthcare sector and the study of multiple healthcare companies, allowing participants to understand the economic logic behind clinical operations and improve their strategic decision-making.

This training does not focus on traditional financial theory; instead, it emphasizes how to use financial information to make better decisions within a medical business.

SOLUTIONS.....
CORPORATE FINANCE & HEALTHCARE MARKET INTELLIGENCE

Proyekta Data Solutions

Corporate Financial Intelligence

300+ healthcare organizations analyzed in Colombia. Intelligence for smarter decisions. | Pharmaceuticals, Medical Devices, Clinical laboratories, Private Hospitals, Prepaid Healthcare, Distributors, Logistic Operators & Pharmacies.

Request a demo...

corregida ingles.png

Global Health Intelligence

Healthcare Market Intelligence

Real-world intelligence on market size, market share, and competitive dynamics.

BrandTrack

by GHI

Request a demo...

Global Healthcare Market Intelligence

We transform complex data into strategic insights

that drive sustainable decisions in healthcre

HEALTHCARE ECOSYSTEM

STRATEGIC ALLIANCE

GHI-Green&White.png

Combining Global Healthcare Intelligence with Advanced Financial Analytics to Deliver Better Strategic Decisions.

WhatsApp Image 2026-08-04 at 5.34_edited.jpg

Global Health Intelligence

Global Health Intelligence

Trusted Across Latin America

Financial Intelligence • Market Intelligence • Healthcare Analytics

GHI Headquarters

+1 (305) 938-0234

95 Merrick Way
Floor 3
Coral Gables,FL 33134

mariana@intelligence.health

Mexico Office

+52 (55) 2702-5902

Pestalozzi 923-B
Colonia del Valle,
CDMX 03100

alfredo@intelligence.health

Brazil Office

+55 (14) 99131-6015

Rua Américo Brasiliense,1923
São Paulo,SP,
04715-005

alessandra@intelligence.health

🌐 www.globalhealthintelligence.com

Selected Research & Publications.....
Selected research, financial intelligence and strategic analysis in the healthcare industry.

The Pulse of Colombia’s Healthcare Sector, Part II: Credit Risk and the IPS Investment Crisis
Published by Global Health Intelligence (GHI)

In the second installment of our exclusive financial analysis, led by Germán Chaparro of Proyekta Data Solutions, we dive deep into the critical liquidity crisis facing Health Service Providing Institutions (IPS, by its Spanish acronym). After analyzing a sample of 53 private IPSs, the data reveals a harsh reality for medical device manufacturers and technology providers: the rapid deterioration of hospital cash flows is drastically halting the sector’s modernization.

Today, IPSs are operating at their absolute limit, becoming involuntary financiers of a system that is stifling their capacity to invest.

The Pulse of Colombia’s Healthcare Sector: A Value Chain on the Brink of Illiquidity
Published by Global Health Intelligence (GHI)

According to an exhaustive analysis by GHI, led by Germán Chaparro of Proyekta Data Solutions, Colombia’s healthcare industry is facing a critical paradox. While it remains one of the most vital sectors for both the national economy and social well-being, it has devolved into a highly stressed financial environment that fails to generate economic value for its investors.

For medical device manufacturers, technology providers, hospitals, and other ecosystem stakeholders, understanding the data driving this crisis is no longer just a basic market analysis; it has become an absolute necessity for corporate survival.

Currently, the healthcare system’s value chain is suffering from structural liquidity issues, regulatory dependence, and a troubling rise in credit risk. This crisis cannot be blamed on a single participant, but is best understood from two interconnected angles: the financial collapse of the insurers (EPS, or Health Promotion Entities) and the illusion of profitability among healthcare providers (IPS, or Health Service Providing Institutions).

The Pulse of Colombia’s Healthcare Sector, Part III: The Impact of the Crisis on MedTech Providers
Published by Global Health Intelligence (GHI)

In the third installment of our exclusive analysis, led by Germán Chaparro of Proyekta Data Solutions, we shift our focus to the supplier side: Colombia’s medical device and equipment industry. Based on a consolidated study of 70 representative companies, the data reveals how the liquidity crisis plaguing hospitals and insurers has ultimately reached international manufacturers and distributors.

For parent companies, understanding the systemic risk of this market has become essential. A distributor’s strength can no longer be measured solely by its individual efficiency, but rather by the broader healthcare system’s ability to generate cash.

US Healthcare Valuation.....
Public-market valuation benchmarks for leading U.S. healthcare providers.

bottom of page